Serum biomarkers such as S100β and neurofilament light chain show potential for illuminating the pathophysiology of ICU delirium, particularly astrocytic and axonal injury, but current evidence is limited by methodological inconsistencies and a lack of replication. This evidence concerns the gene S100B and delirium.